GA-68 PSMA PET CT IN PROSTATE CANCER - INITIAL SINGLE SITE EXPERIENCE

被引:0
|
作者
Lenzo, N. [1 ,2 ,3 ,6 ]
Meyrick, D. [1 ,6 ]
Henderson, A. [1 ,4 ]
Wester, H. [5 ]
Lenzo, N. [1 ,2 ,3 ,6 ]
机构
[1] Ocean Mol, Perth, WA, Australia
[2] Fiona Stanley Hosp, Perth, WA, Australia
[3] Notre Dame Univ Australia, Fremantle, WA, Australia
[4] Sir Charles Gairdner Hosp, Nedlands, WA 6009, Australia
[5] Tech Univ Munich, D-80290 Munich, Germany
[6] Univ Western Australia, Nedlands, WA 6009, Australia
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
032
引用
收藏
页码:15 / 15
页数:1
相关论文
共 50 条
  • [41] The Role of Ga-68 PSMA PET / CT in Predicting Lu-177 PSMA Effectiveness: Can We Project the Ga-68 DOTA PET / CT and Lu-177 DOTA Treatment Experience to PSMA?
    Korkmaz, U.
    Soyluoglu, F. S.
    Durmus-Altun, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S468 - S468
  • [42] Evaluating the Effect of Multilabel and Single Label Models on Prostate Cancer Lesion Segmentation in Ga-68 PSMA-11 PET/CT
    Murugesan, Gowtham Krishnan
    Brunner, Eric
    Soni, Rahul
    McCrumb, Diana
    Kumar, Jithendra
    Grigorash, Vasily
    Van Oss, Jeff
    Moore, Stephen
    Peck, Anderson
    Maupin, Kevin
    Chang, Anthony
    Kulkarni, Harshad
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [43] Prospective comparison of 68Ga-RM2 PET/CT and 68Ga-PSMA-617 PET/CT for initial staging of prostate cancer
    Schollhammer, Romain
    De Clermont-Gallerande, Henri
    Robert, Gregoire
    Yacoub, Mokrane
    Lamare, Frederic
    Balamoutoff, Nicolas
    Vimont, Delphine
    Hindie, Elif
    Fernandez, Philippe
    Morgat, Clement
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [44] Prospective comparison of 68Ga-RM2 PET/CT and 68Ga-PSMA-617 PET/CT for initial staging of prostate cancer
    Schollhammer, R.
    Gallerande, H. De Clermont
    Robert, G.
    Yacoub, M.
    Lamare, F.
    Balamoutoff, N.
    Vimont, D.
    Hindie, E.
    Fernandez, P.
    Morgat, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S279 - S279
  • [45] Ga-68 PSMA PET/CT Imaging Findings of Cholangiocellular Carcinoma
    Kissa, T.
    Genc, Z. C. Balaban
    Niftaliyeva, X.
    Filizoglu, N.
    Kesim, S.
    Oksuzoglu, K.
    Cagliyan, F.
    Ozguven, S.
    Dede, F.
    Ones, T.
    Turoglu, H. T.
    Erdil, T. Y.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S505 - S505
  • [46] Ga 68 PSMA PET/CT at the initial staging of high-risk patients with prostate cancer
    Pipikos, T.
    Vogiatzis, M.
    Andreou, J.
    Kechagias, D.
    Fillipi, V.
    Oikonomou, E.
    Gogos, K.
    Merisoglou, S.
    Papoutsani, D.
    Dalianis, K.
    Efthimiadou, R.
    Prassopoulos, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S453 - S454
  • [47] Assessment Ga-68 PSMA progress in patient with prostate cancer
    Aghaenejad, R. R. Farshbaf
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S878 - S878
  • [48] Ga-68 PSMA PET/CT in metastatic or locally recurrent prostate cancer: Comparison to bone scan, CTor MRI
    Acar, E.
    Bekis, R.
    Ozdogan, O.
    Polack, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S345 - S345
  • [49] Initial experience with Ga-68 FAPI PET/CT for evaluation of Cavernous Sinus Syndrome
    Mittal, Bhagwant
    Kumar, Rajender
    Singh, Harmandeep
    Mahdi, Raza Abbas
    Shukla, Jaya
    Takkar, Aastha
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [50] In Ga-68 PSMA PET/CT Treatment Response Evaluation in Prostate Cancer; the Effect of Tissue Heterogeneity on Treatment Response
    Avci, M.
    Erdogan, M.
    Yildiz, M.
    Sengul, S. S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S763 - S763